kabutan

OLYMPUS CORPORATION(7733) Summary

7733
TSE Prime
OLYMPUS CORPORATION
1,613.5
JPY
-239.0
(-12.90%)
Feb 16, 3:24 pm JST
10.53
USD
Feb 16, 1:24 am EST
Result
PTS
outside of trading hours
1,612.5
Feb 16, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
32.6
PBR
2.30
Yield
1.86%
Margin Trading Ratio
9.23
Stock Price
Feb 16, 2026
Opening Feb 16, 9:12 am
1,667.5 JPY 10.90 USD
Previous Close Feb 13
1,852.5 JPY 12.09 USD
High Feb 16, 9:12 am
1,667.5 JPY 10.90 USD
Low Feb 16, 2:04 pm
1,603.0 JPY 10.46 USD
Volume
11,285,100
Trading Value
0.02T JPY 0.12B USD
VWAP
1622.91 JPY 10.6 USD
Minimum Trading Value
161,350 JPY 1,053 USD
Market Cap
1.80T JPY 0.01T USD
Number of Trades
13,130
Liquidity & Number of Trades
As of Feb 16, 2026
Liquidity
High
1-Year Average
6,335
1-Year High Jun 25, 2025
26,126
Margin Trading
Date Short Interest Long Margin Positions Ratio
Feb 6, 2026 135,200 768,000 5.68
Jan 30, 2026 143,700 779,200 5.42
Jan 23, 2026 152,600 702,000 4.60
Jan 16, 2026 173,800 460,000 2.65
Jan 9, 2026 184,400 468,800 2.54
Company Profile
OLYMPUS CORPORATION is the world leader in endoscopy, with a high market share in gastrointestinal devices. The company focuses on medical-related products, including therapeutic devices.
Sector
Precision Instruments
OLYMPUS CORPORATION operates in three business segments: Endoscopic Solutions, Therapeutic Solutions, and Scientific Solutions. The Endoscopic Solutions division provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Solutions division offers products for gastroenterology, urology, respiratory, energy devices, ENT, and gynecology. The Scientific Solutions division handles biomaterials and orthopedic instruments. The company also engages in holding company activities and financial investments.